Skip to content

Palvella Therapeutics

US · PVLA #2822 by market cap Listed 1970
142.85 -2.92 -2.00%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
B
Momentum strategy signal
Hold
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 12 analysts

Buy
Avg price target 227.73 +59.4%
Price target rangecurrent 142.85
Low207.00
Avg227.73
High246.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-09 CCORF -- Buy 243.00
2026-11-06 Craig-Hallum -- Buy 230.00
2026-11-06 Raymond James -- Buy 230.00
2026-11-06 Truist Financial -- Buy 207.00
2026-11-06 H.C. Wainwright -- Buy 246.00
2026-11-06 Oppenheimer -- Buy 232.00
2026-11-05 BTIG -- Buy 215.00
2026-10-29 Mizuho Securities -- Buy 232.00
2026-10-28 William Blair -- Buy --
2026-10-21 Cantor Fitzgerald -- Buy 210.00
2026-10-20 Clear Street -- Buy 220.00
2026-10-20 H.C. Wainwright -- Buy 246.00
2026-10-16 Raymond James -- Buy --
2026-10-15 William Blair -- Buy 266.00
2026-10-12 BTIG -- Buy 215.00
2026-10-12 H.C. Wainwright -- Buy 246.00
2026-09-21 Chardan Capital -- Buy 240.00
2026-09-10 Mizuho Securities -- Buy 240.00
2026-08-31 Mizuho Securities -- Buy 240.00
2026-08-05 CCORF -- Buy 232.00
2026-08-05 LifeSci Capital -- Buy 236.00
2026-08-05 Truist Financial -- Buy 207.00
2026-08-05 H.C. Wainwright -- Buy 270.00
2026-08-05 Oppenheimer -- Buy 210.00
2026-08-04 TD Cowen -- Buy 267.00

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-05 -- ±8.76% -3.35% (in line)
2026/Q2 2026-08-04 -- ±11.09% +7.96% (in line)
2026/Q1 2026-05-07 -- ±8.37% -12.99% (beat)
2025/Q4 2026-03-31 -- ±12.16% +12.64% (beat)
2025/Q3 2025-11-11 -- ±9.99% -3.04% (in line)
2025/Q2 2025-08-14 -- -- +3.27%
2025/Q1 2025-05-15 -- -- -0.41%
2024/Q4 2025-03-31 -- -- -0.39%

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Palvella Therapeutics discussion 0 comments

Add a comment